A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

NCT03987763 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: IDP-122 Lotion

Sponsor

Bausch Health Americas, Inc.